Correlation Between Adaptive Biotechnologies and Ikena Oncology
Can any of the company-specific risk be diversified away by investing in both Adaptive Biotechnologies and Ikena Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adaptive Biotechnologies and Ikena Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adaptive Biotechnologies Corp and Ikena Oncology, you can compare the effects of market volatilities on Adaptive Biotechnologies and Ikena Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adaptive Biotechnologies with a short position of Ikena Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adaptive Biotechnologies and Ikena Oncology.
Diversification Opportunities for Adaptive Biotechnologies and Ikena Oncology
0.32 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Adaptive and Ikena is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Adaptive Biotechnologies Corp and Ikena Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ikena Oncology and Adaptive Biotechnologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adaptive Biotechnologies Corp are associated (or correlated) with Ikena Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ikena Oncology has no effect on the direction of Adaptive Biotechnologies i.e., Adaptive Biotechnologies and Ikena Oncology go up and down completely randomly.
Pair Corralation between Adaptive Biotechnologies and Ikena Oncology
Given the investment horizon of 90 days Adaptive Biotechnologies Corp is expected to generate 4.11 times more return on investment than Ikena Oncology. However, Adaptive Biotechnologies is 4.11 times more volatile than Ikena Oncology. It trades about 0.03 of its potential returns per unit of risk. Ikena Oncology is currently generating about -0.01 per unit of risk. If you would invest 467.00 in Adaptive Biotechnologies Corp on August 27, 2024 and sell it today you would earn a total of 2.00 from holding Adaptive Biotechnologies Corp or generate 0.43% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Adaptive Biotechnologies Corp vs. Ikena Oncology
Performance |
| Timeline |
| Adaptive Biotechnologies |
| Ikena Oncology |
Adaptive Biotechnologies and Ikena Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Adaptive Biotechnologies and Ikena Oncology
The main advantage of trading using opposite Adaptive Biotechnologies and Ikena Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adaptive Biotechnologies position performs unexpectedly, Ikena Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ikena Oncology will offset losses from the drop in Ikena Oncology's long position.| Adaptive Biotechnologies vs. Verve Therapeutics | Adaptive Biotechnologies vs. Beam Therapeutics | Adaptive Biotechnologies vs. Caribou Biosciences | Adaptive Biotechnologies vs. Sana Biotechnology |
| Ikena Oncology vs. Eliem Therapeutics | Ikena Oncology vs. HCW Biologics | Ikena Oncology vs. Scpharmaceuticals | Ikena Oncology vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |